| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 502 |
| 1 | CLOZAPINE | 380 |
| 2 | OLANZAPINE | 366 |
| 3 | ARIPIPRAZOLE ORAL | 311 |
| 4 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 311 |
| 5 | RISPERIDONE | 272 |
| 6 | QUETIAPINE | 240 |
| 7 | PALIPERIDONE PALMITATE | 217 |
| 8 | LORAZEPAM | 117 |
| 9 | HALOPERIDOL LACTATE | 116 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUAZEPAM | 4 | 0.0132 |
| 1 | AMISULPRIDE | 61 | 0.0100 |
| 2 | PALIPERIDONE PALMITATE | 217 | 0.0066 |
| 3 | ARIPIPRAZOLE LAUROXIL | 26 | 0.0056 |
| 4 | OLANZAPINE | 366 | 0.0052 |
| 5 | HALOPERIDOL LACTATE | 116 | 0.0047 |
| 6 | ARIPIPRAZOLE | 502 | 0.0041 |
| 7 | LOXAPINE | 16 | 0.0040 |
| 8 | BENZTROPINE | 27 | 0.0036 |
| 9 | RISPERIDONE | 272 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 1133 |
| 1 | Benzodiazepine [EPC] | 279 |
| 2 | Mood Stabilizer [EPC] | 136 |
| 3 | Anti-epileptic Agent [EPC] | 135 |
| 4 | Typical Antipsychotic [EPC] | 115 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 78 |
| 6 | Dopamine-2 Receptor Antagonist [EPC] | 61 |
| 7 | Proton Pump Inhibitor [EPC] | 60 |
| 8 | Corticosteroid [EPC] | 59 |
| 9 | Central Nervous System Stimulant [EPC] | 42 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 61 | 0.0078 |
| 1 | Typical Antipsychotic [EPC] | 115 | 0.0046 |
| 2 | Cortisol Synthesis Inhibitor [EPC] | 2 | 0.0026 |
| 3 | Atypical Antipsychotic [EPC] | 1133 | 0.0025 |
| 4 | Influenza A M2 Protein Inhibitor [EPC] | 27 | 0.0017 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Ergot Derivative [EPC] | 7 | 0.0014 |
| 7 | Sigma-1 Agonist [EPC] | 9 | 0.0010 |
| 8 | Catechol-O-Methyltransferase Inhibitor [EPC] | 5 | 0.0010 |
| 9 | Nonergot Dopamine Agonist [EPC] | 15 | 0.0010 |